Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation

PHASE3CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

August 31, 2006

Conditions
Scorpion Sting Envenomation
Interventions
BIOLOGICAL

Antivenin Centruroides (scorpion) equine immune F(ab')2

3 vials of Alacramyn reconstituted in 50 ml of normal saline as an IV infusion over 10 minutes.

Trial Locations (1)

Unknown

Children's Hospital of Morelos, Cuernavaca

All Listed Sponsors
collaborator

University of Arizona

OTHER

collaborator

Universidad Nacional Autonoma de Mexico

OTHER

lead

Instituto Bioclon S.A. de C.V.

INDUSTRY

NCT01599923 - Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation | Biotech Hunter | Biotech Hunter